Alongside immunotherapy or chemo, the wearable device helped patients live longer in a trial, though the results are somewhat controversial.
The FDA has implemented a partial hold on a phase 3 non-small cell lung cancer trial run by BioNTech and OncoC4 after seeing ...
BioNTech (NASDAQ:BNTX) shares fell Friday after the company said it had been informed by partner OncoC4 that FDA placed ...
The FDA has granted approval for Novocure‘s wearable medical device, Optune Lua, designed to treat advanced non-small cell ...
The FDA approved a wearable tumor-treating fields (TTFields) device (Optune Lua) for concurrent use with a PD-1/PD-L1 ...
Registration is open for the University of Mississippi Medical Center (UMMC) Cancer Center and Research Institute’s (CCRI) ...
Chalfont ten-year-old Frankie Wilson, who became a cancer advocate five years ago following her father’s diagnosis, has also ...
ROANOKE, Va. (WDBJ) - National lung cancer screening day is Saturday, Nov. 9, and Carilion is scheduling appointments for ...
When you think of lung cancer treatment, what comes to mind—chemotherapy, radiation, surgery? While these can be crucial, ...
A significant weapon in the fight against lung cancer may be going to waste, as a survey revealed most Americans aren’t aware ...
Good Samaritan will be having Lung Cancer Screening Days at the beginning of November. Those who are eligible include people ...
The changes were based on an analysis of data from the Cancer Intervention and Surveillance Modeling Network that estimated ...